Skip to content
NYSE: IGC
|
Borse Berlin: IGS1.BE
|
Frankfurt: IGS1
IGC
India Globalization Capital Inc.
Menu
Home
Life Sciences
Infrastructure Business
Investors
Press Releases
SEC Filings
XBRL Files
Leadership
Governance
IGC Filed a Patent for a New Formulation to Treat Pain
July 21, 2020
by
Alejandro
Post navigation
← IGC Receives a Notice of Allowance from the U.S. Patent Office
IGC Form 8-K →
